{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:31:08Z","timestamp":1786991468021,"version":"build-2736575974"},"reference-count":42,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100005496","name":"American Foundation for Pharmaceutical Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005496","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","japha.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.japh.2024.102291","type":"journal-article","created":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T21:15:16Z","timestamp":1731705316000},"page":"102291","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Availability of and attitudes toward harm reduction services: A rural pharmacy perspective"],"prefix":"10.1016","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7507-0631","authenticated-orcid":false,"given":"Grace","family":"Marley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Blythe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3497-0406","authenticated-orcid":false,"given":"Salisa","family":"Westrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2025-8140","authenticated-orcid":false,"given":"Delesha M.","family":"Carpenter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Pt 2","key":"10.1016\/j.japh.2024.102291_bib1","article-title":"The fourth wave of the US opioid epidemic and its implications for the rural US: a federal perspective","volume":"152","author":"Jenkins","year":"2021","journal-title":"Prev Med"},{"issue":"6","key":"10.1016\/j.japh.2024.102291_bib2","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1080\/09595230600944529","article-title":"A\u00a0review of the efficacy and effectiveness of harm reduction strategies for alcohol, tobacco and illicit drugs","volume":"25","author":"Ritter","year":"2006","journal-title":"Drug Alcohol Rev"},{"issue":"31","key":"10.1016\/j.japh.2024.102291_bib3","doi-asserted-by":"crossref","first-page":"679","DOI":"10.15585\/mmwr.mm6831e1","article-title":"Vital signs: pharmacy-based naloxone dispensing - United States, 2012-2018","volume":"68","author":"Guy","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.japh.2024.102291_bib4","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.drugpo.2019.09.021","article-title":"Attitudes and availability: a comparison of naloxone dispensing across chain and independent pharmacies in rural and urban areas in Alabama","volume":"74","author":"Sisson","year":"2019","journal-title":"Int J Drug Policy"},{"issue":"1","key":"10.1016\/j.japh.2024.102291_bib5","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13011-021-00402-w","article-title":"Naloxone availability in independent community pharmacies in Georgia, 2019","volume":"16","author":"Gilbert","year":"2021","journal-title":"Subst Abuse Treat Prev Pol"},{"issue":"1","key":"10.1016\/j.japh.2024.102291_bib6","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12954-021-00517-0","article-title":"Pharmacist attitudes and provision of harm reduction services in North Carolina: an exploratory study","volume":"18","author":"Parry","year":"2021","journal-title":"Harm Reduct J"},{"issue":"12","key":"10.1016\/j.japh.2024.102291_bib7","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1111\/add.13517","article-title":"Community pharmacist knowledge, attitudes and confidence regarding naloxone for overdose reversal","volume":"111","author":"Nielsen","year":"2016","journal-title":"Addiction"},{"issue":"3","key":"10.1016\/j.japh.2024.102291_bib8","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1080\/08897077.2017.1391924","article-title":"Barriers and facilitators to dispensing of intranasal naloxone by pharmacists","volume":"39","author":"Bakhireva","year":"2018","journal-title":"Subst Abus"},{"key":"10.1016\/j.japh.2024.102291_bib10","article-title":"Factors in rural community buprenorphine dispensing","volume":"9","author":"Major","year":"2023","journal-title":"Explor Res Clin Soc Pharm"},{"issue":"1","key":"10.1016\/j.japh.2024.102291_bib11","doi-asserted-by":"crossref","DOI":"10.24926\/iip.v10i1.1425","article-title":"Pharmacists\u2019 opinions on the implementation of HIV and HepC point-of-care-testing in a U.S. Pharmacy chain","volume":"10","author":"So","year":"2019","journal-title":"Innov Pharm"},{"key":"10.1016\/j.japh.2024.102291_bib12","article-title":"Community pharmacist engagement in HIV and HCV prevention: current practices and potential for service uptake","volume":"4","author":"Dowling-McClay","year":"2021","journal-title":"Explor Res Clin Soc Pharm"},{"key":"10.1016\/j.japh.2024.102291_bib14","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.drugpo.2018.08.007","article-title":"Fentanyl test strips as an opioid overdose prevention strategy: findings from a syringe services program in the Southeastern United States","volume":"63","author":"Peiper","year":"2019","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.japh.2024.102291_bib15","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.drugpo.2018.09.009","article-title":"Use of rapid fentanyl test strips among young adults who use drugs","volume":"61","author":"Krieger","year":"2018","journal-title":"Int J Drug Policy"},{"issue":"1","key":"10.1016\/j.japh.2024.102291_bib18","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12954-023-00739-4","article-title":"North Carolina pharmacists\u2019 willingness to sell fentanyl test strips: a survey study","volume":"20","author":"Marley","year":"2023","journal-title":"Harm Reduct J"},{"issue":"2","key":"10.1016\/j.japh.2024.102291_bib19","first-page":"524","article-title":"The availability of fentanyl test strips in Georgia community pharmacies","volume":"64","author":"Rawal","year":"2024","journal-title":"J\u00a0Am Pharmaceut Assoc"},{"issue":"10 Suppl 5","key":"10.1016\/j.japh.2024.102291_bib22","doi-asserted-by":"crossref","first-page":"S413","DOI":"10.1097\/MLR.0000000000001612","article-title":"Which definition of rurality should I use?: the relative performance of 8 federal rural definitions in identifying rural-urban disparities","volume":"59","author":"Long","year":"2021","journal-title":"Medical Care"},{"issue":"1","key":"10.1016\/j.japh.2024.102291_bib23","first-page":"68","article-title":"A\u00a0Brief online training to address pharmacists\u2019 willingness to dispense buprenorphine","volume":"18","author":"Carpenter","year":"2024","journal-title":"J\u00a0Addict Med"},{"issue":"5","key":"10.1016\/j.japh.2024.102291_bib24","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/j.japh.2022.04.019","article-title":"North Carolina community pharmacists' buprenorphine dispensing practices and attitudes","volume":"62","author":"Carpenter","year":"2022","journal-title":"J\u00a0Am Pharm Assoc"},{"key":"10.1016\/j.japh.2024.102291_bib25","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.drugpo.2018.02.024","article-title":"Predicting pharmacy syringe sales to people who inject drugs: policy, practice and perceptions","volume":"56","author":"Meyerson","year":"2018","journal-title":"Int J Drug Policy"},{"issue":"5","key":"10.1016\/j.japh.2024.102291_bib26","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1331\/JAPhA.2014.14045","article-title":"HIV testing in community pharmacies and retail clinics: a model to expand access to screening for HIV infection","volume":"54","author":"Weidle","year":"2014","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"issue":"6","key":"10.1016\/j.japh.2024.102291_bib27","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1007\/s10461-020-03111-w","article-title":"The role of pharmacies in the HIV prevention and care continuums: a systematic review","volume":"25","author":"Crawford","year":"2021","journal-title":"AIDS Behav"},{"issue":"9","key":"10.1016\/j.japh.2024.102291_bib28","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.2105\/AJPH.2012.301178","article-title":"Randomized, community-based pharmacy intervention to expand services beyond sale of sterile syringes to injection drug users in pharmacies in New York City","volume":"103","author":"Crawford","year":"2013","journal-title":"Am J Public Health"},{"issue":"4","key":"10.1016\/j.japh.2024.102291_bib29","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1177\/1090198114529131","article-title":"Community impact of pharmacy-Randomized intervention to Improve access to syringes and services for injection drug users","volume":"41","author":"Crawford","year":"2014","journal-title":"Health Educ Behav"},{"issue":"1","key":"10.1016\/j.japh.2024.102291_bib30","first-page":"176","article-title":"Individual- and neighborhood-level characteristics associated with support of in-pharmacy vaccination among ESAP-registered pharmacies: pharmacists\u2019 role in reducing racial\/ethnic disparities in influenza vaccinations in New York City","volume":"88","author":"Crawford","year":"2011","journal-title":"J\u00a0Urban Health"},{"issue":"Suppl 1","key":"10.1016\/j.japh.2024.102291_bib31","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1177\/00333549161310S116","article-title":"Pharmacy intervention to improve HIV testing uptake using a comprehensive health screening approach","volume":"131","author":"Crawford","year":"2016","journal-title":"Public Health Rep"},{"issue":"4","key":"10.1016\/j.japh.2024.102291_bib32","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1331\/JAPhA.2012.10194","article-title":"Pharmacy staff characteristics associated with support for pharmacy-based HIV testing","volume":"52","author":"Amesty","year":"2012","journal-title":"J\u00a0Am Pharm Assoc"},{"issue":"2_suppl","key":"10.1016\/j.japh.2024.102291_bib33","doi-asserted-by":"crossref","first-page":"34S","DOI":"10.1177\/0033354918801026","article-title":"The \u201cNo Wrong door\u201d Approach to HIV testing: results from a Statewide retail pharmacy-based HIV testing program in Virginia, 2014-2016","volume":"133","author":"Collins","year":"2018","journal-title":"Public Health Rep"},{"issue":"1","key":"10.1016\/j.japh.2024.102291_bib34","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1331\/JAPhA.2015.14069","article-title":"Consumer interest in community pharmacy HIV screening services","volume":"55","author":"Darin","year":"2015","journal-title":"J\u00a0Am Pharm Assoc"},{"issue":"1","key":"10.1016\/j.japh.2024.102291_bib35","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1331\/JAPhA.2015.14070","article-title":"Pharmacist-provided rapid HIV testing in two community pharmacies","volume":"55","author":"Darin","year":"2015","journal-title":"J\u00a0Am Pharm Assoc"},{"issue":"6","key":"10.1016\/j.japh.2024.102291_bib36","first-page":"942","article-title":"Pharmacist and pharmacy staff experiences with non-prescription (NP) sale of syringes and attitudes toward providing HIV prevention services for injection drug users (IDUs) in Providence, RI","volume":"87","author":"Zaller","year":"2010","journal-title":"J\u00a0Urban Health"},{"issue":"6","key":"10.1016\/j.japh.2024.102291_bib37","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1331\/JAPhA.2013.12240","article-title":"Pharmacists\u2019 perspectives on HIV testing in community pharmacies","volume":"53","author":"Ryder","year":"2013","journal-title":"J\u00a0Am Pharm Assoc"},{"issue":"1","key":"10.1016\/j.japh.2024.102291_bib38","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12954-023-00767-0","article-title":"Differences in drug use behaviors that impact overdose risk among individuals who do and do not use fentanyl test strips for drug checking","volume":"20","author":"Tilhou","year":"2023","journal-title":"Harm Reduct J"},{"issue":"4","key":"10.1016\/j.japh.2024.102291_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph19042230","article-title":"The impact of the COVID-19 Pandemic on drug Use behaviors, fentanyl exposure, and harm reduction service support among people who Use drugs in rural Settings","volume":"19","author":"Bolinski","year":"2022","journal-title":"Int J Environ Res Public Health"},{"issue":"10","key":"10.1016\/j.japh.2024.102291_bib40","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1080\/10826084.2020.1753773","article-title":"Perspectives on fentanyl test strip use among people who inject drugs in rural Appalachia","volume":"55","author":"Allen","year":"2020","journal-title":"Subst Use Misuse"},{"issue":"1","key":"10.1016\/j.japh.2024.102291_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12954-021-00569-2","article-title":"A\u00a0qualitative study on pharmacy policies toward over-the-counter syringe sales in a rural epicenter of US drug-related epidemics","volume":"19","author":"Fadanelli","year":"2022","journal-title":"Harm Reduct J"},{"issue":"5","key":"10.1016\/j.japh.2024.102291_bib42","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.sapharm.2024.02.001","article-title":"I\u00a0go out of my way to give them an extra smile now:\u2019 A study of pharmacists who participated in respond to prevent, a community pharmacy intervention to accelerate provision of harm reduction materials","volume":"20","author":"Irwin","year":"2024","journal-title":"Res Soc Adm Pharm"},{"key":"10.1016\/j.japh.2024.102291_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2020.102701","article-title":"Buprenorphine dispensing in an epicenter of the U.S. opioid epidemic: a case study of the rural risk environment in Appalachian Kentucky","volume":"85","author":"Cooper","year":"2020","journal-title":"Int J Drug Policy"},{"issue":"3S","key":"10.1016\/j.japh.2024.102291_bib44","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.japh.2020.01.001","article-title":"Indiana community pharmacist preceptors\u2019 knowledge and perceptions of medication-assisted treatment","volume":"60","author":"Davenport","year":"2020","journal-title":"J\u00a0Am Pharm Assoc"},{"issue":"3","key":"10.1016\/j.japh.2024.102291_bib45","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1080\/10826084.2019.1670210","article-title":"Communication experiences of DATA-waivered physicians with community pharmacists: a qualitative study","volume":"55","author":"Ventricelli","year":"2020","journal-title":"Subst Use Misuse"},{"issue":"4","key":"10.1016\/j.japh.2024.102291_bib46","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1080\/08897077.2020.1809605","article-title":"The relationship between knowledge, attitudes, and practices of community pharmacists regarding persons with substance use disorders","volume":"42","author":"Rao","year":"2021","journal-title":"Subst Abuse"},{"key":"10.1016\/j.japh.2024.102291_bib47","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.drugpo.2018.04.004","article-title":"Stigma at every turn: health services experiences among people who inject drugs","volume":"57","author":"Paquette","year":"2018","journal-title":"Int J Drug Policy"},{"issue":"9","key":"10.1016\/j.japh.2024.102291_bib49","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1007\/s10461-013-0593-y","article-title":"Effectiveness of structural-level needle\/syringe programs to reduce HCV and HIV infection among people who inject drugs: a systematic review","volume":"17","author":"Abdul-Quader","year":"2013","journal-title":"AIDS Behav"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319124003224?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319124003224?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T20:38:24Z","timestamp":1741639104000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1544319124003224"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S1544319124003224"],"URL":"https:\/\/doi.org\/10.1016\/j.japh.2024.102291","relation":{},"ISSN":["1544-3191"],"issn-type":[{"value":"1544-3191","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Availability of and attitudes toward harm reduction services: A rural pharmacy perspective","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Pharmacists Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.japh.2024.102291","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102291"}}